Missouri Trust & Investment CO Gilead Sciences, Inc. Transaction History
Missouri Trust & Investment CO
- $283 Million
- Q4 2024
A detailed history of Missouri Trust & Investment CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Missouri Trust & Investment CO holds 1,019 shares of GILD stock, worth $113,914. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,019
Previous 1,000
1.9%
Holding current value
$113,914
Previous $83,000
13.25%
% of portfolio
0.03%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
2,101Shares Held
987MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.02 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.75 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.48 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $140B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...